drugset / Trial / NCT03011307

Efficacy of Intrathecal Oxytocin to Speed Recovery After Hip Surgery

NCT03011307 ↗

Phase 2 Terminated 126 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effect of intrathecal oxytocin on speed of reduction in pain for the first 60 days after hip surgery.

Timeline

Start
2017-01-12
Primary completion
2020-10-23
Completion
2021-08-11

Outcome

Missed primary endpoint

Stopped (Enrollment): “Cessation of funding period prior to completion, due to slow recruitment during the pandemic.”

registry analysis (superiority test); Oxytocin vs Placebo; p = 0.75 NCT03011307 ↗

registry analysis (superiority test); Oxytocin vs Placebo; p = 0.057 NCT03011307 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 100 ug Intrathecal

Indications

No indication recorded.